Speaker: Dr. Gisela Nogales-Gadea is a senior biomedical researcher and group leader at the Badalona Neuromuscular Research Group (GRENBA), part of IGTP.

The DM1-Hub project has created a scientific network in Spain to study the natural history of myotonic dystrophy type 1 (DM1) and aims to identify genomic and proteomic biomarkers for personalized medicine. DM1 is a rare neuromuscular disease with no current treatment and high clinical variability. The project involves more than 100 healthcare professionals collecting lifestyle, clinical, and neuropsychological data from 3,000 patients, along with genomic and proteomic analyses of blood samples. These data will help predict disease severity, organ involvement, stratify patients for clinical trials, and identify new therapeutic targets. DM1-Hub aims to transform patient follow-up protocols, improving quality of life and life expectancy.

Host: Dr. Ramon Martí- Dr. Tomàs Pinós. Neuromuscular and Mitochondrial Pathology -Vall d'Hebron Research Institute (VHIR).

Online: https://gencat.zoom.us/j/83490766597